How AI should be used in radiology: assessing ambiguity and completeness of intended use statements of commercial AI products.

Authors:
van Leeuwen KG; Hedderich DM; Harvey H; Schalekamp S.

Journal:
Insights Imaging

Publication Year: 2024

DOI:
10.1186/s13244-024-01616-9

PMCID:
PMC10873256

PMID:
38366046

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Insights Imaging

Abbreviation: Insights Imaging

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Radiology, Nuclear Medicine & Medical Imaging

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Advancements in diagnostic and interventional radiology for stroke treatment: the path from trial t…
Samuels N; van de Graaf RA; Roos YBWM and 3 more (2024) - Transparency Score: 3/6
A retrospective study on adverse events of intravenous administration of sulfur hexafluoride microb…
Li D; Zhang R; Lan H and 6 more (2024) - Transparency Score: 3/6
Clinical and non-contrast computed tomography characteristics and disease development in patients w…
Wu S; Fan X; Li X and 3 more (2024) - Transparency Score: 3/6
Contrast-enhanced mammography BI-RADS: a case-based approach to radiology reporting.
Nicosia L; Battaglia O; Venturini M and 12 more (2024) - Transparency Score: 3/6
Convolutional neural networks for the differentiation between benign and malignant renal tumors wit…
Klontzas ME; Kalarakis G; Koltsakis E and 3 more (2024) - Transparency Score: 5/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationNot applicable. Competing interestsDMH, SS, and KGvL declare that they have no competing interests.HH: Hardian Limited. Competing interests DMH, SS, and KGvL declare that they have no competing interests. HH: Hardian Limited."

Evidence found in paper:

"Funding No funding."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025